UPDATE: Barclays Capital Initiates Coverage On Celgene On Long-Term Upside Potential

By: via Benzinga
In a report published Tuesday, Barclays Capital analyst Geoffrey Meacham initiated coverage on Celgene Corporation (NASDAQ: CELG) with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.